Satoshi Takahashi
Overview
Explore the profile of Satoshi Takahashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
949
Citations
6745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Konuma T, Hamatani-Asakura M, Monna-Oiwa M, Kato S, Isobe M, Yokoyama K, et al.
Leuk Lymphoma
. 2024 Dec;
:1-11.
PMID: 39618318
We retrospectively investigated the impact of CTLA-4 polymorphism on outcomes for adult patients who received single-unit cord blood transplantation (CBT) at our institution. CTLA-4 genotyping was performed using real-time polymerase...
12.
Kouno N, Takahashi S, Komatsu M, Sakaguchi Y, Ishiguro N, Takeda K, et al.
Bioengineering (Basel)
. 2024 Nov;
11(11).
PMID: 39593814
Objective physical function assessment is crucial for determining patient eligibility for treatment and adjusting the treatment intensity. Existing assessments, such as performance status, are not well standardized, despite their frequent...
13.
Jo T, Inoue K, Ueda T, Iwasaki M, Akahoshi Y, Nishiwaki S, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):247.
PMID: 39587218
Background: The advantage of intensified myeloablative conditioning (MAC) over standard MAC has not been determined in haematopoietic stem cell transplantation (HSCT) for adult acute lymphoblastic leukemia (ALL) patients. Methods: To...
14.
Ohyama K, Katagiri S, Takahashi S, Ayuhara H, Takeuchi H, Akahane D, et al.
Int J Clin Pharmacol Ther
. 2024 Nov;
63(1):30-37.
PMID: 39565078
Objective: Aplastic anemia (AA) is a life-threatening disease, and drug-induced AA is rare. Recently, studies on cases that possibly developed AA following osimertinib treatment have been conducted. This study evaluated...
15.
Hamamoto R, Komatsu M, Yamada M, Kobayashi K, Takahashi M, Miyake M, et al.
Cancer Sci
. 2024 Nov;
116(2):297-307.
PMID: 39557634
The expectations for artificial intelligence (AI) technology have increased considerably in recent years, mainly due to the emergence of deep learning. At present, AI technology is being used for various...
16.
Isobe M, Kato S, Suzuki M, Nannya Y, Takahashi S, Konuma T
Mycopathologia
. 2024 Oct;
189(6):95.
PMID: 39470913
No abstract available.
17.
Ezoe A, Todaka D, Utsumi Y, Takahashi S, Kawaura K, Seki M
Plant J
. 2024 Oct;
120(3):1190-1205.
PMID: 39428689
A series of polyploidizations in higher-order polyploids is the main event affecting gene content in a genome. Each polyploidization event can lead to massive functional divergence because of the subsequent...
18.
Salama Y, Munakata S, Osada T, Takahashi S, Hattori K, Heissig B
Cell Death Dis
. 2024 Oct;
15(10):753.
PMID: 39419989
MicroRNAs, including the tumor-suppressor miR-126 and the oncogene miR-221, regulate tumor formation and growth in colitis-associated cancer (CAC) and colorectal cancer (CRC). This study explores the impact of the epithelial...
19.
Watanabe K, Hosomi Y, Naoki K, Nakahara Y, Tsukita Y, Matsumoto H, et al.
JTO Clin Res Rep
. 2024 Oct;
5(11):100720.
PMID: 39416709
Introduction: Osimertinib is used as the first-line treatment for EGFR mutation-positive NSCLC. Nevertheless, its efficacy and safety in clinical practice remain to be fully elucidated and the pattern of progression...
20.
Takahashi S, Toda M
World Neurosurg X
. 2024 Oct;
24:100398.
PMID: 39386926
The study included 12 hemispheres of 9 patients with moyamoya disease who underwent direct-indirect revascularization. The parameters (peak systolic velocity (PSV), mean flow velocity (MV), resistance index (RI), flow volume...